Publications by authors named "Runkun Han"

Claim this Profile
E
Extracellular vesicles derived EBV tegument protein BRRF2 suppresses cGAS phase separation to promote anti-viral innate immune evasion.
Zhu-Long Hu, Zi-Qian Li, Yu Wang, Yi-Ling Luo, Wan-Ping Guo, Le-Le Zhang, Run-Kun Han

Nat Commun· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A large-scale population-based study reveals that gp42-IgG antibody is protective against EBV-associated nasopharyngeal carcinoma.
Xiang-Wei Kong, Guo-Long Bu, Hua Chen, Yu-Hua Huang, Zhiwei Liu, Shang-Hang Xie, Run-Kun Han, Ao Zhang

J Clin Invest· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning models for predicting of PD-1 treatment efficacy in Pan-cancer patients based on routine hematologic and biochemical parameters.
Wenjian Yang, Cui Chen, Qiangqiang Ouyang, Runkun Han, Peng Sun

Cancer Cell Int· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A nomogram based on the SII3 and clinical indicators predicts survival in patients with nasopharyngeal carcinoma treated with PD-1 inhibitors.
Xiongyi Chen, Wenjing Liang, Xiaowen Wu, Yueying Wang, Yansui Hong, Runkun Han

Medicine (Baltimore)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel model for predicting prognosis and response to immunotherapy in nasopharyngeal carcinoma patients.
Ya-Xian Wu, Bo-Yu Tian, Xin-Yuan Ou, Meng Wu, Qi Huang, Run-Kun Han

Cancer Immunol Immunother· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Clinically Oriented Model to Predict Antitumor Effects after PD-1/PD-L1 Inhibitor Therapy.
Xueping Wang, Zhonglian He, Wen Liu, Runkun Han, Huilan Li, Lin Zhang

J Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fecal CEA Has an Advantage in the Diagnosis of Colorectal Cancer at Early Stage.
Linfang Li, Shan Xing, Miantao Wu, Yufeng Ao, Xin Zheng, Runkun Han

Cancer Control· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma.
Ao Zhang, Guanqing Zhong, Luocan Wang, Rongzeng Cai, Runkun Han

Cancer Cell Int· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma.
Xiaobin Wu, Runkun Han, Yanping Zhong, Nuoqing Weng, Ao Zhang

Cancer Cell Int· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of 2 Commercially Systems for Detection of Serum Squamous Cell Carcinoma Antigen in Pan Squamous Cell Carcinoma.
Hao Chen, Liru Tian, Jiahong Chen, Peng Sun, Runkun Han

Cancer Control· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Survival Advantage of Females at Premenopausal Age Is Race Dependent in Colorectal Cancer.
Hui Sheng, Xiaoli Wei, Qunxi Chen, Kewei Huang, Runkun Han

Biomed Res Int· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma.
Ao Zhang, Guanqing Zhong, Luocan Wang, Rongzeng Cai, Runkun Han

Cancer Cell Int· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma.
Xianbin Wu, Runkun Han, Yanping Zhong, Nuoqing Weng, Ao Zhang

Cancer Cell Int· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heat Shock Protein 90α Provides an Effective and Novel Diagnosis Strategy for Nasopharyngeal Carcinoma.
Minjie Mao, Xueping Wang, Hui Sheng, Huilan Li, Wen Liu, Runkun Han

Adv Ther· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Prognostic Scores Based on Plasma Prothrombin Time and Fibrinogen Levels in Patients With AFP-Negative Hepatocellular Carcinoma.
Minjie Mao, Xueping Wang, Yiling Song, Hui Sheng, Runkun Han

Cancer Control· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel prognostic scores based on serum ferritin/globulin ratio in patients with hepatocellular carcinoma.
Wen Liu, Qunxi Chen, Minjie Mao, Runkun Han, Yijun Liu

Transl Cancer Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis